Clinical Trials
2 trialsNCT00097903 2020-03-12
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
BioNumerik Pharmaceuticals, Inc.
Phase 1 Completed
NCT00010218 2016-07-19
Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed